Form 4 for MAIA MAIA Biotechnology, Inc.

Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001127602-23-006047 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2023-02-21	2023-02-16+	MAIA	Smith Stan	Dir	P - Purchase	$4.25	+137	514.2K	+0.0%	+$582.25

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-02-17	P	A	75	$4.25	514,246	I See Footnote	—	—	(F1) The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
2	Common	Common Stock	2023-02-16	P	A	62	$4.25	514,171	I See Footnote	—	—	(F1) The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.